EirGen Pharma Eir-012 passes clinical trial

EirGen Pharma are pleased to announce that their treatment for early stage breast cancer  "Eir-012" has  successfully completed clinical studies in December  2007.

EirGen Pharma is a pharmaceutical company based in Waterford, Ireland. Using its purpose built high containment facility; the company specialises in the development, registration and manufacture of high potency solid dose products for global markets.